Why the study?
Does 6 months of GLP-1 RA treatment improve vascular function in severely obese patients with T2DM?
Population
11 severely obese patients with type 2 diabetes mellitus, mean age 55 ± 8 years, 4 females and 7 males, mean…
Comparison
Glucagon-like peptide-1 receptor agonist for 6… vs Baseline (before treatment)
Design
Cohort
Follow-up
6 months
Authors
Loading...
GLP-1 RA did not improve vascular function after 6 months in obese T2DM; leaves open longer-term effects or other populations.
Does 6 months of GLP-1 RA treatment improve vascular function in severely obese patients with T2DM?
Despite improvements in body composition and glycemic control, 6 months of GLP-1 RA treatment did not improve vascular function in severely obese patients with T2DM.
Hopkins et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: